IP Library Granted Patent US 9,042,953
Granted Patent B2
US 9,042,953 · App. 11/681,730 · Granted May 26, 2015

Analyte monitoring device and methods of use

Inventors: James Say (Breckenridge, CO); Michael F. Tomasco (Morgan Hill, CA); Adam Heller (Austin, TX); Yoram Gal (Kibbutz Yagur, IL); Behrad Aria (Alameda, CA); Ephraim Heller (Wilson, WY); Phillip John Plante (Sunnyvale, CA); Mark S. Vreeke (Granger, IN); Fredric C. Colman (Woodside, CA)
Assignee: Abbott Diabetes Care Inc.
A61B5/14865Y10T29/49Y10T29/49124A61M5/1723C12Q1/54A61B5/002A61B5/14532A61B5/14546A61B5/1473A61B5/1486A61B5/7445A61B2560/0252H01L23/3107H01L23/49548H01L2924/19041H01L2924/3011Y10S128/903A61B5/14503A61B5/72G06F19/34H01L2924/0002A61B5/01A61B5/1451A61B5/1495A61B5/4839A61B5/7278A61B5/7282A61B5/7405A61B5/743A61B5/7455
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,042,953
App. No.
11/681,730
Granted
May 26, 2015
Kind
B2
Abstract

An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.

Claims (29)

1. A method, comprising:

positioning at least a portion of an electrochemical sensor in fluid contact with interstitial fluid under a skin layer;

generating one or more signals with the electrochemical sensor corresponding to a monitored analyte level in the interstitial fluid;

communicating with sensor electronics sensor data associated with the generated one or more signals from the electrochemical sensor to a receiver unit;

determining, using a processor of the receiver unit, a rate of change of the monitored analyte level based on the sensor data received from the sensor electronics;

determining, using the processor, whether calibration is appropriate based on the determined rate of change and a characteristic of the electrochemical sensor;

displaying, on a display of the receiver unit, information corresponding to the monitored analyte level after determining whether calibration is appropriate based on the determined rate of change and the characteristic of the electrochemical sensor; and

disabling the display from displaying the information corresponding to the monitored analyte level when the display has not been activated for a predetermined period of time, wherein during the time when the display is disabled, receiving the sensor data from the sensor electronics and processing the sensor data by a processing unit of the receiver unit.

2. The method of claim 1 , wherein determining whether the calibration is appropriate based on the determined rate of change includes comparing the determined rate of change to a predetermined value.

3. The method of claim 2 , wherein the predetermined value is approximately 0.25 mg/dL per minute or less.

4. The method of claim 2 , wherein when the determined rate of change is above the predetermined value, determining that calibration is not appropriate.

5. The method of claim 4 , wherein when it is determined that calibration is not appropriate, waiting a predetermined time period before performing calibration.

6. The method of claim 2 , wherein the predetermined value is approximately 0.5 mg/dL per minute.

7. The method of claim 6 , wherein when the determined rate of change is below the predetermined value, determining that calibration is appropriate.

8. The method of claim 1 , further comprising performing calibration using a blood sample to calibrate the electrochemical sensor signal.

9. The method of claim 1 , wherein the electrochemical sensor includes a plurality of electrodes comprising at least one working electrode, the working electrode including an analyte-responsive enzyme and a mediator, and at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and further wherein at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer.

10. A method, comprising:

positioning at least a portion of an electrochemical sensor in fluid contact with interstitial fluid under a skin layer;

generating a plurality of signals with the electrochemical sensor corresponding to a monitored analyte level in the interstitial fluid;

communicating with sensor electronics sensor data associated with the generated plurality of signals from the electrochemical sensor to a receiver unit;

determining, using a processor of the receiver unit, whether the electrochemical sensor has reached equilibrium based on the received sensor data from the sensor electronics;

determining, using the processor of the receiver unit, that calibration is appropriate based on whether the electrochemical sensor has reached equilibrium;

displaying, on a display of the receiver unit, information corresponding to the monitored analyte level after determining whether calibration is appropriate based on whether the electrochemical sensor has reached equilibrium; and

disabling the display from displaying the information corresponding to the monitored analyte level when the display has not been activated for a predetermined period of time, wherein during the time when the display is disabled, receiving the sensor data from the sensor electronics and processing the sensor data by a processing unit of the receiver unit.

11. The method of claim 10 , wherein determining whether the electrochemical sensor has reached equilibrium includes comparing the sensor data received from the sensor electronics to a predetermined value.

12. The method of claim 11 , further including performing calibration when it is determined that the electrochemical sensor has reached equilibrium.

13. The method of claim 12 , further including waiting a predetermined time period before performing calibration when it is determined that the electrochemical sensor has not reached equilibrium.

14. The method of claim 10 , further comprising performing calibration using a blood sample to calibrate the sensor data.

15. The method of claim 10 , wherein the electrochemical sensor includes a plurality of electrodes comprising at least one working electrode, the working electrode including an analyte-responsive enzyme and a mediator, and at least one of the analyte-responsive enzyme and the mediator is chemically bonded to a polymer disposed on the working electrode, and further wherein at least one of the analyte-responsive enzyme and the mediator is crosslinked with the polymer.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2014
From: SAY, JAMES; TOMASCO, MICHAEL F.; HELLER, ADAM; ARIA, BEHRAD; HELLER, EPHRAIM; PLANTE, PHILLIP JOHN; VREEKE, MARK S.; FRIEDMAN, KEITH A.; COLMAN, FREDRIC C.; GAL, YORAM
To: E. HELLER & CO.
Reel/Frame 033700/0833 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2014
From: E. HELLER & COMPANY, INC.
To: THERASENSE, INC.
Reel/Frame 033700/0849 →
CHANGE OF NAME Recorded Sep 9, 2014
From: THERASENSE, INC.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 033705/0817 →
Continuity (4)
Continuation 10420057 · Apr 18, 2003
Continuation 09667199 · Sep 21, 2000
Continuation 09070677 · Apr 30, 1998
Related Publication 20070213610A1 · Sep 13, 2007